Tianjin TEDA Biomedical Engineering Company Limited
Research Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) on Bullrun: market cap HKD 501.47M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8189.HK
- ExchangeHK
- CountryChina
- SectorBasic Materials
- IndustryAgricultural Inputs
- CurrencyHKD
- Market capHKD 501.47M
- Financial periodFY2025
- RevenueCNY 522.97M
- Revenue growth35.7%
- Net income-CNY 90.82M
- Free cash flow-CNY 62.84M
- Gross margin6.8%
Valuation Snapshot
latest market cap is HKD 501.47M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 522.97M | -CNY 90.82M | -CNY 62.84M | 6.8% | -0.04 | CNY 29.21M | CNY 109.74M | CNY 12.22M |
| FY2024 | CNY 385.48M | -CNY 27.80M | -CNY 28.83M | 5.2% | -0.01 | CNY 25.40M | CNY 159.92M | CNY 22.15M |
| FY2023 | CNY 398.00M | -CNY 20.16M | -CNY 15.62M | 5.4% | -0.01 | CNY 5.93M | CNY 76.96M | CNY 49.95M |
| FY2022 | CNY 403.73M | -CNY 27.45M | -CNY 21.62M | 3.7% | -0.01 | CNY 6.86M | CNY 102.61M | CNY 70.11M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 501.47M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Tianjin TEDA Biomedical Engineering Company Limited
Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. It operates through Fertiliser Products, and AI health & elderly care products and services segments. The company's biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas.
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is Tianjin TEDA Biomedical Engineering Company Limited's market cap?
Tianjin TEDA Biomedical Engineering Company Limited's market capitalization is HKD 501.47M.
What does Tianjin TEDA Biomedical Engineering Company Limited do?
Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. It operates through Fertiliser Products, and AI health & elderly care products and services segments. The company's biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas.